GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » EV-to-EBITDA

Oventus Medical (ASX:OVN) EV-to-EBITDA : -0.10 (As of May. 15, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Oventus Medical's enterprise value is A$0.93 Mil. Oventus Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2021 was A$-8.92 Mil. Therefore, Oventus Medical's EV-to-EBITDA for today is -0.10.

The historical rank and industry rank for Oventus Medical's EV-to-EBITDA or its related term are showing as below:

ASX:OVN's EV-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 16.29
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-15), Oventus Medical's stock price is A$0.02. Oventus Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was A$-0.052. Therefore, Oventus Medical's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Oventus Medical EV-to-EBITDA Historical Data

The historical data trend for Oventus Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical EV-to-EBITDA Chart

Oventus Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21
EV-to-EBITDA
-3.55 -4.55 -2.89 -4.27 -1.69

Oventus Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -4.27 - -1.69 -

Competitive Comparison of Oventus Medical's EV-to-EBITDA

For the Medical Devices subindustry, Oventus Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oventus Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oventus Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Oventus Medical's EV-to-EBITDA falls into.



Oventus Medical EV-to-EBITDA Calculation

Oventus Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.928/-8.922
=-0.10

Oventus Medical's current Enterprise Value is A$0.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oventus Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2021 was A$-8.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oventus Medical  (ASX:OVN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Oventus Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.02/-0.052
=At Loss

Oventus Medical's share price for today is A$0.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oventus Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was A$-0.052.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Oventus Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Oventus Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines